Gsk Dr Reddys Laboratories

Rediff.com » News » Gsk Dr Reddys Laboratories

News for Gsk Dr Reddys Laboratories

Business

Domestic pharma market grew by 6.8% in 2023

The Indian pharmaceutical market (IPM) grew 6.8 per cent to touch a turnover of ~1.93 trillion in calendar year 2023, despite volumes going down marginally by 0.9 per cent. Photograph: Amit......

Dr Reddy's sells US facility to UAE-based Neopharma

The plant and associated facilities focus on manufacturing or packaging Amoxicilin-based products, which include semi-synthetic penicillin Dr Reddy’s Laboratories has sold the antibiotics......

Dr Reddy's Q1 Net up 52.49% at Rs 550 cr

Pharma major Dr Reddy's Laboratories on Wednesday reported 52 per cent jump in net profit at Rs 550.39 crore (Rs 5.5 billion) for the first quarter ended June 30, on the back of North American......

Dr Reddy's: New launches to drive growth

Dr Reddy’s Laboratories (DRL) has surged nearly 21% from its closing low of Rs 1,737.60 on March 01, 2013 on the back of increased traction in approvals from the US Food and Drug......

Dr Reddy's acquires GSK's US penicillin facility

Dr Reddy's Laboratories on Wednesday said it has acquired GlaxoSmithKline's US penicillin manufacturing facility and the rights to the Augmentin and Amoxil brands in the United States for an......

Rediff News

Gsk Dr Reddys Laboratories

News for Gsk Dr Reddys Laboratories

Domestic pharma market grew by 6.8% in 2023

Dr Reddy's sells US facility to UAE-based Neopharma

Dr Reddy's Q1 Net up 52.49% at Rs 550 cr

Dr Reddy's: New launches to drive growth

Dr Reddy's acquires GSK's US penicillin facility

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS